申请人:Zyma SA
公开号:US04885298A1
公开(公告)日:1989-12-05
The invention relates to pharmaceutical preparations containing compounds of formula I ##STR1## in which X represents unsubstituted or substituted amino or a quaternary ammonium salt; halogen, free, etherified or esterified hydroxy; free, etherified, esterified or oxidized mercapto; free or functionally modified carboxyl, free or functionally modified sulfo; acyl; nitro; an unsubstituted or substituted hydrocarbon radical or an unsubstituted or substituted heterocyclic radical, Y represents oxygen, sulfur, sulfinyl or sulfonyl but must be oxygen, sulfinyl or sulfonyl, if X is 1H-imidazol-1-yl, and rings A and B are each unsubstituted or substituted; or pharmaceutically acceptable salts of such compounds that contain a salt-forming group, and to novel compounds of formula I. The compounds are useful e.g. for the treatment of diseases of the respiratory tract and of liver diseases. They are prepared by methods known per se.
该发明涉及含有公式I中化合物的制药制剂,其中X代表未取代或取代的氨基或季铵盐;卤素,自由,醚化或酯化的羟基;自由,醚化,酯化或氧化的巯基;自由或功能修饰的羧基,自由或功能修饰的磺酸基;酰基;硝基;未取代或取代的碳氢基团或未取代或取代的杂环基团,Y代表氧,硫,亚砜或磺酰基,但如果X为1H-咪唑-1-基,则必须为氧,亚砜或磺酰基,并且环A和环B均未取代或取代;或含有成盐基团的这种化合物的药学上可接受的盐,以及公式I的新化合物。这些化合物可用于治疗呼吸道疾病和肝病等疾病。它们通过已知的方法制备。